No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial

10.1371/journal.pone.0109718

Saved in:

Bibliographic Details
Main Authors:	Solomon A., Tennakoon S., Leeansyah E., Arribas J., Hill A., Van Delft Y., Moecklinghoff C., Lewin S.R.
Other Authors:	NUSHS PROJECT
Format:	Article
Published:	2019
Subjects:	darunavir plus ritonavir virus RNA anti human immunodeficiency virus agent darunavir nucleoside ritonavir sulfonamide telomerase adult age Article controlled clinical trial controlled study drug effect female human human cell Human immunodeficiency virus infection major clinical study male monotherapy peripheral blood mononuclear cell randomized controlled trial real time polymerase chain reaction telomere telomere length telomere shortening treatment duration chemistry clinical trial drug combination drug effects genetics HIV Infections Human immunodeficiency virus 1 metabolism middle aged mononuclear cell pathology virology Adult Anti-HIV Agents Drug Therapy, Combination Female HIV-1 Humans Leukocytes, Mononuclear Male Middle Aged Nucleosides Ritonavir RNA, Viral Sulfonamides Telomerase Telomere
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/161761
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-161761
record_format	dspace
spelling	sg-nus-scholar.10635-1617612024-11-09T21:07:18Z No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial Solomon A. Tennakoon S. Leeansyah E. Arribas J. Hill A. Van Delft Y. Moecklinghoff C. Lewin S.R. NUSHS PROJECT DUKE-NUS MEDICAL SCHOOL darunavir plus ritonavir virus RNA anti human immunodeficiency virus agent darunavir nucleoside ritonavir sulfonamide telomerase virus RNA adult age Article controlled clinical trial controlled study drug effect female human human cell Human immunodeficiency virus infection major clinical study male monotherapy peripheral blood mononuclear cell randomized controlled trial real time polymerase chain reaction telomere telomere length telomere shortening treatment duration chemistry clinical trial drug combination drug effects genetics HIV Infections Human immunodeficiency virus 1 metabolism middle aged mononuclear cell pathology telomere virology Adult Anti-HIV Agents Drug Therapy, Combination Female HIV Infections HIV-1 Humans Leukocytes, Mononuclear Male Middle Aged Nucleosides Ritonavir RNA, Viral Sulfonamides Telomerase Telomere 10.1371/journal.pone.0109718 PLoS ONE 9 11 e109718 2019-11-07T05:05:23Z 2019-11-07T05:05:23Z 2014 Article Solomon A., Tennakoon S., Leeansyah E., Arribas J., Hill A., Van Delft Y., Moecklinghoff C., Lewin S.R. (2014). No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial. PLoS ONE 9 (11) : e109718. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0109718 19326203 https://scholarbank.nus.edu.sg/handle/10635/161761 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	darunavir plus ritonavir virus RNA anti human immunodeficiency virus agent darunavir nucleoside ritonavir sulfonamide telomerase virus RNA adult age Article controlled clinical trial controlled study drug effect female human human cell Human immunodeficiency virus infection major clinical study male monotherapy peripheral blood mononuclear cell randomized controlled trial real time polymerase chain reaction telomere telomere length telomere shortening treatment duration chemistry clinical trial drug combination drug effects genetics HIV Infections Human immunodeficiency virus 1 metabolism middle aged mononuclear cell pathology telomere virology Adult Anti-HIV Agents Drug Therapy, Combination Female HIV Infections HIV-1 Humans Leukocytes, Mononuclear Male Middle Aged Nucleosides Ritonavir RNA, Viral Sulfonamides Telomerase Telomere
spellingShingle	darunavir plus ritonavir virus RNA anti human immunodeficiency virus agent darunavir nucleoside ritonavir sulfonamide telomerase virus RNA adult age Article controlled clinical trial controlled study drug effect female human human cell Human immunodeficiency virus infection major clinical study male monotherapy peripheral blood mononuclear cell randomized controlled trial real time polymerase chain reaction telomere telomere length telomere shortening treatment duration chemistry clinical trial drug combination drug effects genetics HIV Infections Human immunodeficiency virus 1 metabolism middle aged mononuclear cell pathology telomere virology Adult Anti-HIV Agents Drug Therapy, Combination Female HIV Infections HIV-1 Humans Leukocytes, Mononuclear Male Middle Aged Nucleosides Ritonavir RNA, Viral Sulfonamides Telomerase Telomere Solomon A. Tennakoon S. Leeansyah E. Arribas J. Hill A. Van Delft Y. Moecklinghoff C. Lewin S.R. No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial
description	10.1371/journal.pone.0109718
author2	NUSHS PROJECT
author_facet	NUSHS PROJECT Solomon A. Tennakoon S. Leeansyah E. Arribas J. Hill A. Van Delft Y. Moecklinghoff C. Lewin S.R.
format	Article
author	Solomon A. Tennakoon S. Leeansyah E. Arribas J. Hill A. Van Delft Y. Moecklinghoff C. Lewin S.R.
author_sort	Solomon A.
title	No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial
title_short	No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial
title_full	No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial
title_fullStr	No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial
title_full_unstemmed	No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial
title_sort	no difference in the rate of change in telomere length or telomerase activity in hiv-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the monet trial
publishDate	2019
url	https://scholarbank.nus.edu.sg/handle/10635/161761
_version_	1821191175855407104

No difference in the rate of change in telomere length or telomerase activity in HIV-Infected patients after three years of darunavir/Ritonavir with and without nucleoside analogues in the monet trial

Similar Items